Company Overview of Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc., together with its subsidiaries, develops proprietary therapies for the treatment of cancer. It also evaluates new therapeutic agents and/or related technologies that involve the examination of individual molecules, classes of compounds, or platform technologies. The company provides therapeutic candidate programs, including TPI 287 IV and TIP 287 oral formulations for prostate, non-small cell lung, and other cancers. The company was founded in 1991 and is based in Boulder, Colorado.
4840 Pearl East Circle
Suite 300 W
Boulder, CO 80301-2408
Founded in 1991
Key Executives for Tapestry Pharmaceuticals, Inc.
Similar Private Companies By Industry
|ProtaTek International, Inc.||United States|
|Sunol Molecular Corporation||United States|
|Transderm Laboratories Corp.||United States|
|Avelis, LLC||United States|
|ZyStor Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Tapestry Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.